What's the Outlook for AstraZeneca Stock?

As one of the world's largest pharmaceutical companies, AstraZeneca (NYSE: AZN) competes in a broad array of disease markets, producing medicines in the oncology, immunology, and cardiovascular segments, just to name a few. AstraZeneca is also one of the world's most prolific drug innovators, claiming 21 different regulatory approvals for its pipeline projects last year alone. What's more, the company is profitable, posting steady revenue growth year over year, and is engaged in a high-profile effort to develop a coronavirus vaccine.